Raze Therapeutics
About:
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Website: http://www.razetx.com/
Twitter/X: razetx
Top Investors: Novartis, Atlas Venture, M Ventures, MPM Capital, Astellas Venture Management
Description:
Raze Therapeutics is leading the discovery and development of a new class of oncology therapeutics that target key metabolic pathways. Raze is advancing a pipeline of therapeutics based on new biological insights into how cancer cells reprogram metabolism to activate central anabolic processes essential for tumors to grow and survive.
$24M
$1M to $10M
Cambridge, Massachusetts, United States
2013-01-01
info(AT)razetx.com
David Sabatini, Joshua Rabinowitz, Vamsi Mootha
1-10
2014-10-14
Private
© 2025 bioDAO.ai